Feature | April 10, 2014

The Role of Magnetic Nanoparticles in Breast Cancer Treatment

Dartmouth to share its plans for clinical tests in humans

Shown here at 9900x magnification, tumor cells readily take up magnetic nanoparticles (black objects). When a tumor containing nanoparticles is exposed to an alternating magnetic field, the nanoparticles will heat and kill the tumor cells.

April 10, 2014 — In a presentation exploring the promise of magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment, Dartmouth researcher P. Jack Hoopes, DMV, Ph.D., co-director of Norris Cotton Cancer Center's Nanotechnology Working Group, reviewed preclinical studies conducted at Norris Cotton Cancer Center and discussed plans for early-phase clinical studies in humans at the annual meeting of the American Association for Cancer Research (AACR).

This evolving treatment approach involves the injection of nanoparticles into the tumor, which are then activated with magnetic energy. Once activated, the nanoparticles produce heat inside the cancer cell, the heat killing it with minimal damage to surrounding tissue.

Hoopes has led efforts in creating platforms, approaches and equipment to test mNP in the laboratory and in the exam room at the Dartmouth Center of Nanotechnology Excellence. He presented the enhanced uptake of breast cancer antibody tagged mNPs in xenograph breast tumors (human tumors grown in mice) following systemic delivery. The antibodies resulted in a 2.5-fold increase in tumor mNPs. The antibodies used were similar to the commercially available breast cancer antibody herceptin (trastuzumab). Researchers used only the cell-binding (fab) fragment of the antibody. This antibody-fab fragment was produced in the Thayer School of Engineering at Dartmouth laboratory of protein engineers Tillman Gerngross and Karl Griswold.

“Although we initially used the mNP therapy in an intra-tumoral delivery manner, and it has been effective, our goal and much of our current research is systemic mNP administration aimed at invasive and metastatic cancer,” said Hoopes. “This is where the antibodies come in and the highly specific magnetic resonance imaging (MRI) -based nanoparticle imaging we are conducting at the Center for Magnetic Resonance Research, University of Minnesota with Professor Michael Garwood.”

Hoopes’ presentation reviewed biodistribution studies in mice, nanoparticle heating characterization in vitro and in vivo, efficacy studies in mouse tumor models and spontaneous canine oropharyngeal tumors, studies combining nanoparticle hyperthermia with ionizing radiation and chemotherapy and MRI-based nanoparticle imaging. He also addressed Dartmouth's preparation for clinical trials, including navigating the Institutional Review Board (IRB) and the U.S. Food and Drug Administration (FDA) and the services provided by the FDA/NIH’s Nanoparticle Characterization Laboratory.

For more information: www.sciencedaily.com/releases/2014/04/140407090226.htm

Related Content

MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area

NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area. Image courtesy of David Vaillancourt, Ph.D., University of Florida.

News | Neuro Imaging | July 31, 2017
Scientists at the University of Florida have discovered a new method of observing the brain changes caused by Parkinson...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
"Residual Echo" of Ancient Humans May Hold Clues to Mental Disorders

MRI data shows (left) areas of the skull preferentially affected by the amount of Neanderthal-derived DNA and (right) areas of the brain’s visual system in which Neanderthal gene variants influenced cortex folding (red) and gray matter volume (yellow). Image courtesy of Michael Gregory, M.D., NIMH Section on Integrative Neuroimaging

News | Neuro Imaging | July 26, 2017
Researchers from the National Institute of Mental Health (NIMH) have produced the first direct evidence that parts of...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Overlay Init